Trousseau Syndrome

Trousseau Syndrome, also known as Trousseau's Sign of Malignancy, is characterized by the occurrence of venous thrombosis and thromboembolism in patients with an underlying malignancy.

This condition is particularly associated with pancreatic, gastric, and lung cancers, among others. The syndrome is a paraneoplastic phenomenon, meaning that it is a disease or symptom that is a consequence of cancer in the body, but not due to the local presence of cancer cells.

---

Causes of Trousseau Syndrome

The pathogenesis of Trousseau Syndrome is multifactorial and involves a complex interplay of procoagulant factors produced by tumour cells and the host's response to these factors. Here are some of the principal causes:

Malignancy-Induced Hypercoagulability

Cancer cells can secrete procoagulant substances, such as tissue factor and cancer procoagulant, which activate the coagulation cascade. This results in a hypercoagulable state that predisposes patients to thrombosis.

Tumor Cell Interaction with Host Cells

Tumor cells can interact with endothelial cells and platelets, promoting clot formation. The expression of adhesion molecules on tumour cells facilitates this interaction, further contributing to thrombogenesis.

Cytokine Release

Cancer can induce the release of cytokines, which play a significant role in coagulation activation. Cytokines such as tumour necrosis factor (TNF) and interleukin-1 (IL-1) can enhance the prothrombotic state by altering the hemostatic balance.

---

Symptoms of Trousseau Syndrome

The symptoms of Trousseau Syndrome can be varied and often mimic other conditions, making diagnosis challenging. Here are the primary symptoms to be aware of:

Migratory Thrombophlebitis

One of the hallmark signs of Trousseau Syndrome is migratory thrombophlebitis, where blood clots cause inflammation in the veins, manifesting as tender nodules along the affected veins. These nodules often appear in different locations over time.

Unexplained Venous Thrombosis

Patients may experience repeated episodes of deep vein thrombosis (DVT) or pulmonary embolism without an obvious cause. Such unexplained thrombotic events in individuals with a high risk of cancer should raise suspicion for Trousseau Syndrome.

Superficial Vein Thrombosis

Unlike typical DVT, superficial vein thrombosis in Trousseau Syndrome may occur more frequently and resolve spontaneously, only to appear elsewhere, contributing to the migratory nature of the condition.

---

Risk Factors and Diagnosis of Trousseau Syndrome

Risk Factors

Diagnosis

Diagnosing Trousseau Syndrome requires a careful evaluation of the patient's medical history, clinical presentation, and diagnostic testing. Laboratory tests may include:

---

Complications and Prognosis

Complications

The primary complication of Trousseau Syndrome is the risk of thromboembolic events, which can lead to significant morbidity and mortality. Pulmonary embolism is a life-threatening complication that requires immediate medical attention.

Prognosis

The prognosis of Trousseau Syndrome largely depends on the underlying malignancy and its stage. Early detection and treatment of the associated cancer can improve outcomes. However, the presence of Trousseau Syndrome often indicates an advanced cancer stage and may be associated with a poorer prognosis.

---

Treatment of Trousseau Syndrome

Anticoagulation Therapy

The cornerstone of treatment is anticoagulation therapy, which helps prevent further thrombotic events. Low molecular weight heparin (LMWH) is often preferred due to its efficacy and safety profile.

Cancer Treatment

Addressing the underlying malignancy is crucial. Surgical resection, chemotherapy, or radiation therapy may be employed depending on the type and stage of cancer.

Risk Factor Management

Managing additional risk factors, such as obesity, immobility, and smoking, can help reduce the risk of thrombotic events.